OXGN strong break higher off of downtrend. Daily chart.
OXGN had a recent spike up off of its long-term downtrend movement. The movement was due to a positive earnings report. Oxigene, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat cancer and eye diseases in the United States. It primarily focuses on the development of product candidates that disable and destroy abnormal blood vessels that provide solid tumors a means of growth and survival, as well as associate with visual impairment in various ophthalmological diseases and conditions.
CLICK HERE for full article.